Therapeutic Asset Ratings

1,482 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Cpx-351 Myelodysplastic Syndrome	National Cancer Institute (NCI)	P2/3	B (63)
Cyclophosphamide Diffuse Large B-Cell Lymphoma With Chronic Inflammation	Mayo Clinic	P2/3	B (63)
Cyclophosphamide Interstitial Lung Disease	Intergroupe Francophone de Cancerologie Thoracique	P2/3	B (63)
Cyclophosphamide Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type	Mayo Clinic	P2/3	B (63)
Decitabine Myelodysplastic Syndrome/Acute Myeloid Leukemia	National Cancer Institute (NCI)	P2/3	B (63)
DEXAMETHASONE Acute Leukemia	SWOG Cancer Research Network	P2/3	B (63)
Docetaxel HER-2 Positive Breast Cancer	Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS	P2/3	B (63)
Equine Atg Leukemia	Peking University People's Hospital	P2/3	B (63)
Fludarabine B Acute Lymphoblastic Leukemia/Lymphoma	Institute of Hematology & Blood Diseases Hospital, China	P2/3	B (63)
FULVESTRANT Breast Tumor Luminal A Or B	BeiGene	P2/3	B (63)
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER Diffuse Large B-Cell Lymphoma With Chronic Inflammation	Mayo Clinic	P2/3	B (63)
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type	Mayo Clinic	P2/3	B (63)
METHADONE Methadone	University of Maryland, Baltimore	P2/3	B (63)
Mitoxantrone Childhood Acute Myeloid Leukemia	Princess Maxima Center for Pediatric Oncology	P2/3	B (63)
Paxalisib Glioblastoma	Institute of Cancer Research, United Kingdom	P2/3	B (63)
Romidepsin Bone Marrow Failure	Memorial Sloan Kettering Cancer Center	P2/3	B (63)
Romidepsin Severe Combined Immunodeficiency	National Institute of Allergy and Infectious Diseases (NIAID)	P2/3	B (63)
Sorafenib Small Cell Lung Carcinoma	Peking Union Medical College Hospital	P2/3	B (63)
T-Dxd HER2 Positive Breast Carcinoma	Peking University Cancer Hospital & Institute	P2/3	B (63)
VITAMIN D Sickle Cell Disease	University of California, Davis	P2/3	B (63)
(±)-1-BUTYL-2',6'-PIPECOLOXYLIDIDE MONOHYDROCHLORIDE B-All	Merck Sharp & Dohme LLC	P2/3	B (62)
Aldafermin Primary Sclerosing Cholangitis	NGM Biopharmaceuticals, Inc	P2/3	B (62)
ALECTINIB Hematopoietic And Lymphoid System Neoplasm	Cancer Research UK	P2/3	B (62)
Anti-Thymoglobulin, Rabbit Fucosidosis	Masonic Cancer Center, University of Minnesota	P2/3	B (62)
Anti-Thymoglobulin, Rabbit Krabbe Disease	Masonic Cancer Center, University of Minnesota	P2/3	B (62)

Showing 301 to 325 of 1,482 assets

PreviousPage 13 of 60Next